Total Payments
$5,074
2024 Payments
$2,030
Companies
10
Transactions
153
Medicare Patients
229
Medicare Billing
$26,209
Payment Breakdown by Category
Food & Beverage$4,963 (97.8%)
Education$111.49 (2.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,963 | 152 | 97.8% |
| Education | $111.49 | 1 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $1,703 | 43 | $0 (2024) |
| Alkermes, Inc. | $868.97 | 32 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $774.00 | 19 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $637.00 | 24 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $498.79 | 14 | $0 (2024) |
| ITI, Inc. | $465.24 | 15 | $0 (2023) |
| Lundbeck LLC | $37.78 | 2 | $0 (2023) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $37.30 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $27.98 | 1 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $24.60 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,030 | 67 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($498.79) |
| 2023 | $2,097 | 71 | Neurocrine Biosciences, Inc. ($672.91) |
| 2022 | $697.29 | 12 | Neurocrine Biosciences, Inc. ($334.75) |
| 2021 | $250.11 | 3 | Neurocrine Biosciences, Inc. ($231.00) |
All Payment Transactions
153 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $46.87 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $30.33 | General |
| Category: CNS | ||||||
| 12/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $30.78 | General |
| Category: Neuropsychiatry | ||||||
| 12/09/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: CNS | ||||||
| 11/27/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $38.73 | General |
| Category: Neuropsychiatry | ||||||
| 11/09/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $105.98 | General |
| Category: CNS | ||||||
| 11/08/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $95.34 | General |
| Category: Central Nervous System | ||||||
| 11/08/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: PSYCHIATRY | ||||||
| 11/08/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: PSYCHIATRY | ||||||
| 11/08/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $2.74 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $9.19 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $4.35 | General |
| Category: CNS | ||||||
| 11/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Neurology | ||||||
| 10/15/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $105.58 | General |
| Category: PSYCHIATRY | ||||||
| 07/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Neuropsychiatry | ||||||
| 07/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: PSYCHIATRY | ||||||
| 07/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: Neuropsychiatry | ||||||
| 07/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: CNS | ||||||
| 07/08/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Neurology | ||||||
| 06/28/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: CNS | ||||||
| 06/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $124.90 | General |
| Category: PSYCHIATRY | ||||||
| 06/20/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: PSYCHIATRY | ||||||
| 06/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 167 | 423 | $161,227 | $21,742 |
| 2022 | 1 | 62 | 72 | $24,514 | $4,467 |
Total Patients
229
Total Services
495
Medicare Billing
$26,209
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 297 | $112,500 | $13,975 | 12.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 49 | 98 | $38,776 | $6,234 | 16.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 16 | $8,055 | $1,370 | 17.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 12 | $1,896 | $163.79 | 8.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 72 | $24,514 | $4,467 | 18.2% |
About Gilda Mark, APRN
Gilda Mark, APRN is a Registered Nurse healthcare provider based in Fort Collins, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/28/2013. The National Provider Identifier (NPI) number assigned to this provider is 1700124617.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Gilda Mark, APRN has received a total of $5,074 in payments from pharmaceutical and medical device companies, with $2,030 received in 2024. These payments were reported across 153 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($4,963).
As a Medicare-enrolled provider, Mark has provided services to 229 Medicare beneficiaries, totaling 495 services with total Medicare billing of $26,209. Data is available for 2 years (2022–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Psychiatric/Mental Health
- Location Fort Collins, CO
- Active Since 01/28/2013
- Last Updated 07/24/2024
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1700124617
Products in Payments
- INGREZZA (Drug) $1,703
- CAPLYTA (Drug) $964.03
- ARISTADA (Drug) $734.39
- Austedo XR (Drug) $336.80
- REXULTI (Drug) $326.51
- ABILIFY MAINTENA (Drug) $243.06
- AUSTEDO (Drug) $162.91
- UZEDY (Drug) $162.80
- ABILIFY ASIMTUFII (Drug) $136.93
- LYBALVI (Drug) $86.84
- Vivitrol (Drug) $47.74
- INVEGA SUSTENNA (Drug) $27.98
- LATUDA (Drug) $24.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Fort Collins
Courtney Weir, Np, NP
Registered Nurse — Payments: $10,855
Registered Nurse $10,855
Rhonda Fisher
Registered Nurse — Payments: $1,751
Registered Nurse $1,751
Keri Ferguson, Np-C, NP-C
Registered Nurse — Payments: $1,447
Registered Nurse $1,447
Dawn O'keefe, Rn Ms Mpa Pmhnp-Bc, RN MS MPA PMHNP-BC
Registered Nurse — Payments: $1,100
Registered Nurse $1,100
Christine Shoaf, Np, NP
Registered Nurse — Payments: $630.33
Registered Nurse $630.33
Vanessa Vasa, Rn, RN
Registered Nurse — Payments: $527.87
Registered Nurse $527.87